S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
LON:BTG

BTG Share Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
840
MA: GBX 840
840
52-Week Range N/A
Volume271,742 shs
Average Volume960,389 shs
Market Capitalization£3.26 billion
P/E Ratio29.47
Dividend YieldN/A
BetaN/A
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.
BTG logo

Headlines

Understanding B2Gold's Ex-Dividend Date
March 4, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-75750000
Employees1,631
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£914.10 million
Book ValueGBX 355.80 per share

Profitability

Miscellaneous

Market Cap£3.26 billion
Next Earnings DateN/A
OptionableOptionable

MarketRank

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive BTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BTG (LON:BTG) Frequently Asked Questions

What stocks does MarketBeat like better than BTG?

Wall Street analysts have given BTG a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BTG wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were BTG's earnings last quarter?

BTG plc (LON:BTG) released its quarterly earnings data on Tuesday, May, 15th. The company reported $32.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $29.80 by $3.10.
View BTG's earnings history
.

Who are BTG's key executives?

BTG's management team includes the following people:
  • Dr. Louise Makin MA, Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director (Age 58)
  • Mr. Duncan Kennedy A.C.A., B.Sc., CFO & Director
  • Dr. Peter Stratford, Chief Technical Officer & Head of Innovation (Age 52)
  • Mr. Andy Burrows, VP of Corp. & Investor Relations
  • Dr. Paul Mussenden, Gen. Counsel, Head of Strategic Affairs & Company Sec.

Who are some of BTG's key competitors?

What other stocks do shareholders of BTG own?

What is BTG's stock symbol?

BTG trades on the London Stock Exchange (LON) under the ticker symbol "BTG."

How do I buy shares of BTG?

Shares of BTG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is BTG's stock price today?

One share of BTG stock can currently be purchased for approximately GBX 840.

How much money does BTG make?

BTG has a market capitalization of £3.26 billion and generates £914.10 million in revenue each year.

How many employees does BTG have?

BTG employs 1,631 workers across the globe.

What is BTG's official website?

The official website for BTG is www.btgplc.com.

Where are BTG's headquarters?

BTG is headquartered at 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom.

How can I contact BTG?

BTG's mailing address is 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom. The company can be reached via phone at +44-20-75750000.


This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.